Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-75
SponsorH. Lee Moffitt Cancer Center and Research Institute
About this trial
This innovative Multilevel Action Toward Colorectal Cancer (CRC) and Hepatitis C Virus (HCV) Education and Screening (MATCHES) intervention aims to promote concurrent HCV and CRC screening among FQHC patients ages 45-75.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Participants must be receiving care at one of the participating FQHC clinics.
Participants must be 45-75 years of age.
Participants must not be up to date with Colorectal Cancer (CRC) screening recommendations such as no colonoscopy in the past 10 years, occult blood test in the past 12 months.
Participants must never have had Hepatitis C Virus (HCV) antibody screening.
Disqualifiers
Participants that do not meet all Inclusion Eligibility requirements will be excluded.
Trial design
Design model
Single group
Treatments tested in this trial
MATCHES
BehavioralParticipants will be asked to complete a survey with specific topics including Hepatitis C (HCV) and Colorectal (CRC) knowledge and health beliefs, screening intentions and demographic characteristics. Participants will be provided with education intervention materials (for example, a booklet) either in-person or via mail, access to free stool-based CRC screening, and access to free HCV screening. Approximately 1-2 weeks after receiving the education materials, participants will be asked to complete a post-intervention survey about the same specific topics (for example, HCV and CRC knowledge, HCV and CRC health beliefs, HCV and CRC screening intentions, healthcare experiences, perceptions of the educational materials) over the phone with a trained study staff. Participants with a positive HCV screening and/or CRC screening result will be navigated to follow-up care as needed.
Treatment groups
350 Participants
are divided into 1 treatment groupGroup A: Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening (MATCHES)Experimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Screening Uptake for Hepatitis C Virus (HCV) and Colorectal Cancer (CRC)
Screening Uptake will be measured by the number of participants who complete both CRC and HCV screening documented via Electronic Health Record (EHR) at 12 months post-intervention.
Time frame
Up to 12 MonthsSecondary outcomes
1
Screening Completion for Hepatitis C Virus (HCV)
Screening Completion for HCV will be measured by the number of participants who complete HCV Screening at any time during the Study Period.
Time frame
Up to 41 Months2
Screening Completion for Colorectal Cancer (CRC)
Screening Completion for CRC will be measured by the number of participants who complete CRC Screening at any time during the Study Period.
Time frame
Up to 41 Months3
Screening Test Results for Hepatitis C (HCV)
Screening Test Results will be measured as abnormal vs normal
Time frame
Up to 41 Months4
Screening Test Results for Colorectal Cancer (CRC)
Screening Test Results will be measured as abnormal vs normal
Time frame
Up to 41 MonthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
H. Lee Moffitt Cancer Center and Research Institute
Lead sponsor
Florida Biomedical Research Program - Bankhead Coley
Collaborator
Source ClinicalTrials.gov